BioSpace News Archive

Ultivue, Inc. and, the Translational Research Unit platform of University of Bern announce a collaborative agreement to promote multiplexed immunofluorescence assays and the use of next generation TMAs to unlock spatial analysis in scientific research and improve the quality of TMAs integrated in clinical and translational research.

Myonex, a leading global clinical trial supply company, announces the launch of the first and only on-demand local drug sourcing in Europe.

Cell coding company bit.bio has announced an expansion to its product portfolio - ioGlutamatergic Neurons TDP-43M337V disease model and early access to its ioMicroglia cell product.

NeuShen Therapeutics, Inc. announced the closure of ~$20 million Series pre-A financing led by LAPAM, a China based venture capital.

Galecto, Inc. announced positive results from a planned intermediate assessment of its ongoing Phase 2a trial of GB2064 for the treatment of myelofibrosis.

Spectrum Chemical Mfg. Corp. has entered into a new U.S. distribution agreement with DFE Pharma, a global leader in pharma and nutraceutical excipient solutions.

Entos Pharmaceuticals, a clinical-stage biotechnology company developing genetic medicines with its Fusogenix proteolipid vehicle nucleic acid delivery platform, and Centre National de Recherche et de Formation sur le Paludisme, the Burkina Faso site team lead by Dr. Gansane Adama, announced that enrollment is now complete into the single and two-dose cohorts of the Phase 2 clinical trial of Covigenix VAX-001-1b, its COVID-19 DNA vaccine.

Axcella Therapeutics reported interim results from their ongoing global Phase 2b randomized, double-blind, placebo-controlled, dose ranging EMMPACT study to evaluate the safety, tolerability, and efficacy of AXA1125 for the treatment of NASH.

Cure Rare Disease, a clinical-stage nonprofit biotechnology company, has acquired its first laboratory space at 4 Research Drive in Woodbridge, Connecticut, where the organization will relocate its headquarters and expand its research and development operations.

MolecuLight Corp. announces it has been awarded a new group purchasing agreement with AllSpire Health GPO, a Mid-Atlantic GPO and a partner of HealthTrust Purchasing Group, engaged with over fifty hospitals in Maryland, New Jersey and Pennsylvania.